Document Detail


A reevaluation of the primary diagnosis of hemangiopericytoma and the clinical importance of differential diagnosis from solitary fibrous tumor of the central nervous system.
MedLine Citation:
PMID:  18922629     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Hemangiopericytomas (HPCs) are rare neoplasms with relatively high rates of recurrence and extracranial metastasis. Though the differential diagnoses from angiomatous meningiomas and from solitary fibrous tumors (SFTs) are both important, the latter diagnosis is somewhat more important in light of the benign prognosis of SFTs and the difficulties in distinguishing SFTs from HPCs. Newly developed immunohistochemical methods reveal differences in the specific immunohistochemical features of HPCs and SFTs. To elucidate whether SFTs have been misdiagnosed as HPCs in the past, our group used recent immunohistochemical methods to re-evaluate tissues that had been originally diagnosed as HPCs. We also compared the clinical features of these cases.
PATIENTS AND METHODS: Thirteen sequential cases of HPC diagnosed in Kanazawa University Hospital and Kumamoto University Hospital between 1970 and 2006 were retrospectively analyzed by immunohistochemical staining for CD34, Bcl-2, epithelial membrane antigen (EMA), vimentin, and S100 protein, and by measurement of the MIB-1 labeling index (LI). The cases were then re-evaluated and newly diagnosed based on the results of the immunohistochemical stainings. The clinical course of each case was also evaluated.
RESULTS: Four of the 13 cases were newly diagnosed as SFTs and eight were reconfirmed as HPCs, based on the immunohistochemical studies for CD34, Bcl-2, and reticulin staining. One case was newly diagnosed as meningioma on the basis of a strong EMA positivity. The MIB-1 LI was less than 1% in 12 of the cases. In two cases, one case of HPC and the other of meningioma, the MIB-1 LI was relatively high, 8% and 4% respectively. All eight of the HPCs recurred, and 5 of the HPC patients died of the disease. Only one case of the SFTs recurred.
CONCLUSION: Our study suggests that a relatively high percentage of the tumors diagnosed as HPCs in the past may have in fact been intracranial SFTs. Immunohistochemical examinations of CD34, Bcl-2, and reticulin stains are keys for the differential diagnosis. Given that SFTs have a considerably better prognosis than HPCs, it is important to carry out meticulous immunohistochemical examinations for the primary diagnosis.
Authors:
Yutaka Hayashi; Naoyuki Uchiyama; Yasuhiko Hayashi; Mitsutoshi Nakada; Masayuki Iwato; Daisuke Kita; Ryo Higashi; Yuichi Hirota; Yutaka Kai; Jun-ichi Kuratsu; Jun-ichiro Hamada
Related Documents :
1174189 - Pulmonary and articular sporotrichosis. report of two cases.
17573569 - Occupational noise-induced hearing loss reports and tinnitus in finland.
1812769 - Preconception tort liability: recognizing a strict liability cause of action for des gr...
7341039 - Record of hospitalized acute intoxication cases: a proposed statistical-epidemiological...
18420879 - Successful resuscitation after ropivacaine and lidocaine-induced ventricular arrhythmia...
3903639 - Intussusception: indications for ultrasonography and an explanation of the doughnut and...
7796069 - Generalized nonconvulsive status epilepticus after electroconvulsive therapy.
7439239 - Incomplete interpolation caused by sinoatrial pacemaker shift. a report of two cases.
22385269 - Type i cryoglobulinemia in multiple myeloma: a rare entity. analysis of clinical and bi...
Publication Detail:
Type:  Journal Article     Date:  2008-10-14
Journal Detail:
Title:  Clinical neurology and neurosurgery     Volume:  111     ISSN:  1872-6968     ISO Abbreviation:  Clin Neurol Neurosurg     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2008-12-22     Completed Date:  2009-02-19     Revised Date:  2010-12-07    
Medline Journal Info:
Nlm Unique ID:  7502039     Medline TA:  Clin Neurol Neurosurg     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  34-8     Citation Subset:  IM    
Affiliation:
Department of Neurosurgery, Kanazawa University Hospital, Kanazawa, Japan. yuh@ns.m.kanazawa-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Antigens, CD34 / metabolism
Central Nervous System Neoplasms / diagnosis*,  metabolism
Diagnosis, Differential
Female
Hemangiopericytoma / diagnosis*,  metabolism
Humans
Immunohistochemistry
Ki-67 Antigen / metabolism
Male
Meningioma / diagnosis*,  metabolism
Middle Aged
Mucin-1 / metabolism
Prognosis
Proto-Oncogene Proteins c-bcl-2 / metabolism
Retrospective Studies
S100 Proteins / metabolism
Solitary Fibrous Tumors / diagnosis*,  metabolism
Tumor Markers, Biological / metabolism*
Vimentin / metabolism
Chemical
Reg. No./Substance:
0/Antigens, CD34; 0/Ki-67 Antigen; 0/Mucin-1; 0/Proto-Oncogene Proteins c-bcl-2; 0/S100 Proteins; 0/Tumor Markers, Biological; 0/Vimentin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Assessment of verbal memory by fMRI: lateralization and functional neuroanatomy.
Next Document:  Traumatic aneurysm of the occipital artery secondary to paintball injury.